After a couple of blistering weeks, large funding rounds slowed down to a crawl, with only two rounds hitting nine figures.
Hayward, California-based drug startup Eikon Therapeutics closed a nearly $351 million Series D in the second-biggest round ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback